From: The prognostic significance of tumour-stroma ratio in endometrial carcinoma
Clinicopathological data | Median (range) |
---|---|
Age (years) at diagnosis | 66 (28–95) |
 | N (%) |
Histopathological subtype | Â |
 Endometrioid | 302 (75.5) |
 Serous | 34 (8.5) |
 Clear cell | 11 (2.8) |
 Mixed | 50 (12.5) |
 Undifferentiated | 1 (0.25) |
 Mucinous | 2 (0.5) |
Surgical stage (FIGO 2009) | Â |
 I | 262 (65.5) |
 II | 39 (9.8) |
 III | 75 (18.8) |
 IV | 24 (6.0) |
Grade | Â |
 1 | 149 (37.25) |
 2 | 106 (26.5) |
 3 | 145 (36.25) |
Type of surgery | Â |
 Total abdominal hysterectomy | 345 (86.3) |
 Laparoscopic assisted vaginal hysterectomy | 55 (13.8) |
 Bilateral salpingo-oophorectomy | 391 (97.8) |
 Lymphadenectomy | 324 (81.0) |
 Omental biopsy | 50 (12.5) |
 Omentectomy | 89 (22.5) |
Adjuvant therapy | Â |
 Radiotherapy alone | 98 (24.5) |
 Chemotherapy alone | 17 (4.25) |
 Radiotherapy + chemotherapy | 45 (11.25) |
 No adjuvant treatment | 240 (60) |